Literature DB >> 17032403

Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations.

Elisabetta Buscarini1, Henry Plauchu, Guadalupe Garcia Tsao, Robert I White, Carlo Sabbà, Franklin Miller, Jean Cristophe Saurin, Jean Pierre Pelage, Gaetan Lesca, Marie Jeanne Marion, Annalisa Perna, Marie E Faughnan.   

Abstract

STUDY
PURPOSE: To formulate recommendations about clinical management of liver involvement in hereditary hemorrhagic telangiectasia (HHT), using a formal consensus development process. CONSENSUS PROCESS: A nominal group technique was used. A list of main clinical, diagnostic and therapeutic issues about liver involvement in HHT was generated by the organizing committee. Panel members then scored their agreement with each statement; the median score, and standard deviation for each statement were determined for each of the three successive panel rounds. These consensus statements formed the basis for recommendations graded with the strength and quality of supporting evidence. RECOMMENDATION STATEMENTS: Doppler US is sufficiently accurate and suitable for first-line imaging of the liver in the general HHT population. Liver biopsy in any patient with proven or suspected HHT should be avoided. Liver involvement in HHT is generally asymptomatic; in the minority of patients where it is symptomatic, morbidity and mortality can be substantial. The prevalence of focal nodular hyperplasia is much higher in patients with liver involvement by HHT than in the general population. Invasive therapies for liver involvement by HHT (namely liver transplantation) should be considered only in patients who have failed to respond to intensive medical therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17032403     DOI: 10.1111/j.1478-3231.2006.01340.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  31 in total

1.  [64-year old patient with tachycardia and signs of heart failure].

Authors:  M M Zaruba; T Waggershauser; S Weckbach; A Gerbes; O Mühling; S Kääb
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

Review 2.  Hereditary hemorrhagic telangiectasia of the liver complicated by ischemic bile duct necrosis and sepsis: case report and review of the literature.

Authors:  Anastasios Mavrakis; Anthony Demetris; Erin Rubin Ochoa; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2009-09-16       Impact factor: 3.199

3.  Successful liver transplantation for Rendu-Weber-Osler disease, a single centre experience.

Authors:  Murat Cag; Maxime Audet; Anne-Catherine Saouli; Murad Odeh; Bernard Ellero; Tullio Piardi; Marie-Lorraine Woehl-Jaeglé; Jacques Cinqualbre; Philippe Wolf
Journal:  Hepatol Int       Date:  2011-02-17       Impact factor: 6.047

Review 4.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Dynamic 4D MR angiography versus multislice CT angiography in the evaluation of vascular hepatic involvement in hereditary haemorrhagic telangiectasia.

Authors:  A Scardapane; A Stabile Ianora; C Sabbà; M Moschetta; P Suppressa; L Castorani; G Angelelli
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

6.  Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect?

Authors:  Marcello Candelli; Maurizio Pompili; Patrizia Suppressa; Gennaro M Lenato; Giulia Bosco; Gian Ludovico Rapaccini; Antonio Gasbarrini; Arnaldo Scardapane; Carlo Sabbà
Journal:  Intern Emerg Med       Date:  2011-02-09       Impact factor: 3.397

7.  Hereditary hemorrhagic telangiectasia with multiple hepatic and pulmonary nodular lesions.

Authors:  Yasuyuki Shimoyama; Satoru Kakizaki; Akiko Katano; Satoshi Takakusaki; Masafumi Mizuide; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori
Journal:  Clin J Gastroenterol       Date:  2009-01-10

8.  Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Nicola Alessi; Giuseppe Cabibbo; Daniela Cabibi
Journal:  World J Hepatol       Date:  2013-05-27

Review 9.  Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality.

Authors:  A P Brady; M M Murphy; T M O'Connor
Journal:  Ir J Med Sci       Date:  2008-10-16       Impact factor: 1.568

Review 10.  Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Authors:  Fatima S Govani; Claire L Shovlin
Journal:  Eur J Hum Genet       Date:  2009-04-01       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.